Publications by the researcher in collaboration with JOSÉ VICENTE LAFUENTE SÁNCHEZ (213)

2023

  1. Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles

    Neurochemical Research, Vol. 48, Núm. 6, pp. 1864-1888

  2. Clinical phenotype of postural orthostatic tachycardia associated with anti-adrenergic receptor antibodies

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 120, Núm. 2, pp. 66-73

  3. Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma

    Advances in neurobiology, Vol. 32, pp. 195-229

  4. Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury

    International Review of Neurobiology (Academic Press Inc.), pp. 145-185

  5. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury

    Advances in Neurobiology (Springer), pp. 97-138

  6. Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment

    Advances in neurobiology, Vol. 32, pp. 271-313

  7. Comparative Effect between Antidepressants and D-phenylalanine, a Phenethylamine Precursor, in an Animal Model of Depression

    Archives of psychiatry research, Vol. 59, Núm. 2, pp. 219-224

  8. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  9. Effects of curcumin nanodelivery on schizophrenia and glioblastoma

    International Review of Neurobiology (Academic Press Inc.), pp. 163-203

  10. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  11. Enriched environment as a nonpharmacological neuroprotective strategy

    Experimental Biology and Medicine

  12. MISATTRIBUTION OF EMOTIONAL OVER-AROUSAL TO NEUTRAL FACES IN ACUTE PARANOID SCHIZOPHRENIA PSYCHOSIS

    Psychiatria Danubina, Vol. 35, Núm. 4, pp. 515-522

  13. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease

    Advances in neurobiology, Vol. 32, pp. 55-96

  14. Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury

    International Review of Neurobiology (Academic Press Inc.), pp. 37-77

  15. Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation

    Advances in neurobiology, Vol. 32, pp. 3-53

  16. Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following Brain Blast Injury

    Advances in neurobiology, Vol. 32, pp. 231-270

  17. Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor

    Advances in neurobiology, Vol. 32, pp. 385-416

  18. Nanowired Delivery of Mesenchymal Stem Cells with Antioxidant Compound H-290/51 Reduces Exacerbation of Methamphetamine Neurotoxicity in Hot Environment

    Advances in neurobiology, Vol. 32, pp. 317-352